Klauschen Frederick

Klauschen Frederick serves as a Member of the Board of Directors at Bayerisches Zentrum für Krebsforschung (BZKF) since January 2024. Additionally, Klauschen holds the position of Professor of Pathology and Director of the Institute of Pathology at Ludwig-Maximilians-Universität München, a role initiated in February 2021. As Co-Founder and Chief Medical Advisor at Aignostics since March 2020, Klauschen plays a pivotal role in the company’s operations. Furthermore, Klauschen has been a Professor of Molecular Pathology and Deputy Director at Charité - Universitätsmedizin Berlin since May 2009, along with multiple other significant titles such as Senior Consultant Pathologist and Research Group Leader. Prior experience includes a postdoctoral research position at the National Institutes of Health from April 2004 to April 2009. Klauschen holds a Habilitation in Experimental Pathology from Charité - Universitätsmedizin Berlin, a Master's Degree in Physics from the University of Hamburg, and a Doctor of Medicine (M.D.) from Universität zu Lübeck.